David A. Flockhart, MD, PhD
- 5Articles
- 62.3KReads1
- 2012Active
- 6Collaborators
- 173Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
David A. Flockhart, MD, PhD, has published extensively on monoamine oxidase inhibitors (MAOIs), focusing on their dietary restrictions and drug interactions in the treatment of depression (MDD). His work includes updates and discussions on the clinical use of MAOIs, addressing important considerations for managing patients with depression. He has collaborated frequently with co-authors such as Chad M. VanDenBerg, David A. Sclar, Larry Culpepper, Lawrence J. Cohen, and Michael E. Thase.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
